The prediction role of indexes of circulating adipokines for common anthropometric and nutritional characteristics of obesity in the obese Central European population

Eating Behaviors

Volumn 15, Issue 2, 2014, Pages 244-251

  Bienertová Vašků, Julie ^a   Novák, Jan ^a   Zlámal, Filip ^a   Forejt, Martin ^a   Havlenová, Soňa ^a   Jackowská, Aneta ^a   Tomandl, Josef ^a   Tomandlová, Marie ^a   Šplíchal, Zbyněk ^a   Vašků, Anna ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Adipokine; Correlation; Index; Leptin; Nutrition; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AGOUTI RELATED PROTEIN; COMPLEMENT FACTOR D; LEPTIN; LEPTIN RECEPTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; RESISTIN; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CAUCASIAN; CONTROLLED STUDY; EUROPE; FAT MASS; FEMALE; FOOD COMPOSITION; HIP CIRCUMFERENCE; HORMONE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOKINE; CORRELATION; INDEX; LEPTIN; NUTRITION; OBESITY;

ADIPOKINES; ADIPONECTIN; ADULT; AGOUTI-RELATED PROTEIN; ANTHROPOMETRY; BIOLOGICAL MARKERS; COMPLEMENT FACTOR D; CYTOKINES; CZECH REPUBLIC; DIET; FEMALE; GPI-LINKED PROTEINS; HEALTH STATUS INDICATORS; HUMANS; LECTINS; LEPTIN; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NUTRITIONAL STATUS; OBESITY; RECEPTORS, LEPTIN; RESISTIN;

EID: 84897404181     PISSN: 14710153     EISSN: 18737358     Source Type: Journal    
DOI: 10.1016/j.eatbeh.2014.03.001     Document Type: Article

References (24)

1. Bays H.E. "Sick fat," metabolic disease, and atherosclerosis. American Journal of Medicine 2009, 122:S26-S37.
2. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 2005, 96:939-949.
3. Bluher M. Adipose tissue dysfunction in obesity. Experimental and Clinical Endocrinology and Diabetes 2009, 117:241-250.
4. Bluher M. Do adipokines link obesity to its related metabolic and cardiovascular diseases?. Clinical Lipidology 2010, 5:95-107.
5. Bluher M. Clinical relevance of adipokines. Diabetes and Metabolism Journal 2012, 36:317-327.
6. Bluher M., Rudich A., Kloting N., Golan R., Henkin Y., Rubin E., et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012, 35:342-349.
7. Breitling R. Robust signaling networks of the adipose secretome. Trends in Endocrinology and Metabolism 2009, 20:1-7.
8. Fain J.N., Sacks H.S., Buehrer B., Bahouth S.W., Garrett E., Wolf R.Y., et al. Identification of omentin mRNA in human epicardial adipose tissue: Comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. International Journal of Obesity 2008, 32:810-815.
9. Flier J.S., Cook K.S., Usher P., Spiegelman B.M. Severely impaired adipsin expression in genetic and acquired obesity. Science 1987, 237:405-408.
10. Labruna G., Pasanisi F., Nardelli C., Caso R., Vitale D.F., Contaldo F., et al. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) 2011, 19:1492-1496.
11. Lau C.H., Muniandy S. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: A case control study. Cardiovascular Diabetology 2011, 10:8.
12. Lehr S., Hartwig S., Sell H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clinical Applications 2012, 6:91-101.
13. LeRoith D., Novosyadlyy R., Gallagher E.J., Lann D., Vijayakumar A., Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Experimental and Clinical Endocrinology and Diabetes 2008, 116(Suppl. 1):S4-S6.
14. Ma Y., Bertone E.R., Stanek E.J., Reed G.W., Hebert J.R., Cohen N.L., et al. Association between eating patterns and obesity in a free-living US adult population. American Journal of Epidemiology 2003, 158:85-92.
15. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology 2003, 14:561-566.
16. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011, 11:85-97.
17. Rubio-Guerra A.F., Cabrera-Miranda L.J., Vargas-Robles H., Maceda-Serrano A., Lozano-Nuevo J.J., Escalante-Acosta B.A. Correlation between levels of circulating adipokines and adiponectin/resistin index with carotid intima-media thickness in hypertensive type 2 diabetic patients. Cardiology 2013, 125:150-153.
18. Sell H., Dietze-Schroeder D., Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends in Endocrinology and Metabolism 2006, 17:416-422.
19. Schaffler A., Neumeier M., Herfarth H., Furst A., Scholmerich J., Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et Biophysica Acta 2005, 1732:96-102.
20. Siiteri P.K. Adipose tissue as a source of hormones. American Journal of Clinical Nutrition 1987, 45:277-282.
21. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
22. Varela L., Horvath T.L. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Reports 2012, 13:1079-1086.
23. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Reviews 2000, 21:697-738.
24. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.